Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Research Report 2021

1 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Overview

• 1.1 Product Overview and Scope of 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13)
• 1.2 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Segment by Type
  • 1.2.1 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Growth Rate Comparison by Type (2021-2027)
  • 1.2.2 Serotype 6B
  • 1.2.3 7F Serotype
  • 1.2.4 Serotype 9V
  • 1.2.5 14 Serotype
  • 1.2.6 Serotype 18C
  • 1.2.7 Serotype 19A
  • 1.2.8 19F Serotype
  • 1.2.9 23F Serotype
  • 1.2.10 24F Serotype
  • 1.2.11 Other
• 1.3 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Segment by Application
  • 1.3.1 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Comparison by Application: (2021-2027)
  • 1.3.2 Infants from 6 Weeks to 15 Months Old
  • 1.3.3 Children Aged 15 Months to 5 Years
• 1.4 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Size Estimates and Forecasts
  • 1.4.1 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue 2016-2027
  • 1.4.2 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales 2016-2027
  • 1.4.3 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Size by Region: 2016 Versus 2021 Versus 2027

2 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Competition by Manufacturers

• 2.1 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Market Share by Manufacturers (2016-2021)
• 2.2 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Market Share by Manufacturers (2016-2021)
• 2.3 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Average Price by Manufacturers (2016-2021)
• 2.4 Manufacturers 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Manufacturing Sites, Area Served, Product Type
• 2.5 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Competitive Situation and Trends
  • 2.5.1 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Concentration Rate
  • 2.5.2 The Global Top 5 and Top 10 Largest 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Players Market Share by Revenue
  • 2.5.3 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Retrospective Market Scenario by Region

• 3.1 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Retrospective Market Scenario in Sales by Region: 2016-2021
• 3.2 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Retrospective Market Scenario in Revenue by Region: 2016-2021
• 3.3 North America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Facts & Figures by Country
  • 3.3.1 North America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales by Country
  • 3.3.2 North America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue by Country
  • 3.3.3 United States
  • 3.3.4 Canada
• 3.4 Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Facts & Figures by Country
  • 3.4.1 Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales by Country
  • 3.4.2 Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue by Country
  • 3.4.3 Germany
  • 3.4.4 France
  • 3.4.5 U.K.
  • 3.4.6 Italy
  • 3.4.7 Russia
• 3.5 Asia Pacific 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Facts & Figures by Region
  • 3.5.1 Asia Pacific 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales by Region
  • 3.5.2 Asia Pacific 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue by Region
  • 3.5.3 China
  • 3.5.4 Japan
  • 3.5.5 South Korea
  • 3.5.6 India
  • 3.5.7 Australia
  • 3.5.8 Taiwan
  • 3.5.9 Indonesia
  • 3.5.10 Thailand
  • 3.5.11 Malaysia
• 3.6 Latin America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Facts & Figures by Country
  • 3.6.1 Latin America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales by Country
  • 3.6.2 Latin America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue by Country
  • 3.6.3 Mexico
  • 3.6.4 Brazil
  • 3.6.5 Argentina
  • 3.6.6 Colombia
• 3.7 Middle East and Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Facts & Figures by Country
  • 3.7.1 Middle East and Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales by Country
  • 3.7.2 Middle East and Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue by Country
  • 3.7.3 Turkey
  • 3.7.4 Saudi Arabia
  • 3.7.5 UAE

4 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Historic Market Analysis by Type

• 4.1 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Market Share by Type (2016-2021)
• 4.2 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Market Share by Type (2016-2021)
• 4.3 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Price by Type (2016-2021)

5 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Historic Market Analysis by Application

• 5.1 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Market Share by Application (2016-2021)
• 5.2 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Revenue Market Share by Application (2016-2021)
• 5.3 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Price by Application (2016-2021)

6 Key Companies Profiled

• 6.1 Pfizer
  • 6.1.1 Pfizer Corporation Information
  • 6.1.2 Pfizer Description and Business Overview
  • 6.1.3 Pfizer 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales, Revenue and Gross Margin (2016-2021)
  • 6.1.4 Pfizer 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Product Portfolio
  • 6.1.5 Pfizer Recent Developments/Updates
• 6.2 Minhai Bio
  • 6.2.1 Minhai Bio Corporation Information
  • 6.2.2 Minhai Bio Description and Business Overview
  • 6.2.3 Minhai Bio 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales, Revenue and Gross Margin (2016-2021)
  • 6.2.4 Minhai Bio 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Product Portfolio
  • 6.2.5 Minhai Bio Recent Developments/Updates
• 6.3 Kexing Bio
  • 6.3.1 Kexing Bio Corporation Information
  • 6.3.2 Kexing Bio Description and Business Overview
  • 6.3.3 Kexing Bio 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales, Revenue and Gross Margin (2016-2021)
  • 6.3.4 Kexing Bio 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Product Portfolio
  • 6.3.5 Kexing Bio Recent Developments/Updates
• 6.4 Cansino Bio
  • 6.4.1 Cansino Bio Corporation Information
  • 6.4.2 Cansino Bio Description and Business Overview
  • 6.4.3 Cansino Bio 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales, Revenue and Gross Margin (2016-2021)
  • 6.4.4 Cansino Bio 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Product Portfolio
  • 6.4.5 Cansino Bio Recent Developments/Updates
• 6.5 Lanzhou Biological Preparations Institute
  • 6.5.1 Lanzhou Biological Preparations Institute Corporation Information
  • 6.5.2 Lanzhou Biological Preparations Institute Description and Business Overview
  • 6.5.3 Lanzhou Biological Preparations Institute 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales, Revenue and Gross Margin (2016-2021)
  • 6.5.4 Lanzhou Biological Preparations Institute 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Product Portfolio
  • 6.5.5 Lanzhou Biological Preparations Institute Recent Developments/Updates

7 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Manufacturing Cost Analysis

• 7.1 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Key Raw Materials Analysis
  • 7.1.1 Key Raw Materials
  • 7.1.2 Key Suppliers of Raw Materials
• 7.2 Proportion of Manufacturing Cost Structure
• 7.3 Manufacturing Process Analysis of 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13)
• 7.4 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

• 8.1 Marketing Channel
• 8.2 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Distributors List
• 8.3 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Customers

9 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Dynamics

• 9.1 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Industry Trends
• 9.2 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Growth Drivers
• 9.3 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Challenges
• 9.4 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Restraints

10 Global Market Forecast

• 10.1 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Estimates and Projections by Type
  • 10.1.1 Global Forecasted Sales of 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) by Type (2022-2027)
  • 10.1.2 Global Forecasted Revenue of 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) by Type (2022-2027)
• 10.2 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Estimates and Projections by Application
  • 10.2.1 Global Forecasted Sales of 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) by Application (2022-2027)
  • 10.2.2 Global Forecasted Revenue of 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) by Application (2022-2027)
• 10.3 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Estimates and Projections by Region
  • 10.3.1 Global Forecasted Sales of 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) by Region (2022-2027)
  • 10.3.2 Global Forecasted Revenue of 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source

• 12.1 Methodology/Research Approach
  • 12.1.1 Research Programs/Design
  • 12.1.2 Market Size Estimation
  • 12.1.3 Market Breakdown and Data Triangulation
• 12.2 Data Source
  • 12.2.1 Secondary Sources
  • 12.2.2 Primary Sources
• 12.3 Author List